219 related articles for article (PubMed ID: 21651427)
21. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
[TBL] [Abstract][Full Text] [Related]
22. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
23. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
24. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
25. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD.
Liu SF; Kuo HC; Liu GH; Ho SC; Chang HC; Huang HT; Chen YM; Huang KT; Chen KY; Fang WF; Lin MC
Int J Chron Obstruct Pulmon Dis; 2016; 11():1607-14. PubMed ID: 27478374
[TBL] [Abstract][Full Text] [Related]
26. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
27. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence.
Schmier JK; Halpern MT; Jones ML
Drugs Aging; 2005; 22(9):717-29. PubMed ID: 16156676
[TBL] [Abstract][Full Text] [Related]
28. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
Chalmers JD; Poole C; Webster S; Tebboth A; Dickinson S; Gayle A
Respir Res; 2018 Apr; 19(1):63. PubMed ID: 29642882
[TBL] [Abstract][Full Text] [Related]
29. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation.
Cydulka RK; Rowe BH; Clark S; Emerman CL; Rimm AR; Camargo CA
Acad Emerg Med; 2005 Dec; 12(12):1173-9. PubMed ID: 16282511
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain).
Román-Rodríguez M; van Boven JF; Vargas F; Contreras CC; Lamelas G; Gestoso S; Góngora M; Corredor M; Esteva M
Eur J Gen Pract; 2016 Dec; 22(4):232-239. PubMed ID: 27597172
[TBL] [Abstract][Full Text] [Related]
31. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period.
Krigsman K; Moen J; Nilsson JL; Ring L
J Clin Pharm Ther; 2007 Dec; 32(6):603-11. PubMed ID: 18021338
[TBL] [Abstract][Full Text] [Related]
32. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
[TBL] [Abstract][Full Text] [Related]
33. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
34. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
[TBL] [Abstract][Full Text] [Related]
35. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease.
Akazawa M; Hayflinger DC; Stanford RH; Blanchette CM
Am J Manag Care; 2008 Jul; 14(7):438-48. PubMed ID: 18611095
[TBL] [Abstract][Full Text] [Related]
36. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.
Wu N; Chen S; Boulanger L; Fraser K; Bledsoe SL; Zhao Y
J Med Econ; 2009 Sep; 12(3):192-202. PubMed ID: 19705975
[TBL] [Abstract][Full Text] [Related]
37. The place of inhaled corticosteroids in chronic obstructive pulmonary disease.
Selroos O
Curr Med Res Opin; 2004 Oct; 20(10):1579-93. PubMed ID: 15462691
[TBL] [Abstract][Full Text] [Related]
38. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
Kiri VA; Bettoncelli G; Testi R; Viegi G
Respir Med; 2005 Sep; 99(9):1115-24. PubMed ID: 15921904
[TBL] [Abstract][Full Text] [Related]
39. [Inhaled corticosteroids for COPD].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 2003 Jul; 147(29):1398-404. PubMed ID: 12894463
[TBL] [Abstract][Full Text] [Related]
40. Use of inhaled corticosteroids following discharge from an emergency department for an acute exacerbation of asthma.
Blais L; Beauchesne MF
Thorax; 2004 Nov; 59(11):943-7. PubMed ID: 15516468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]